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Abstract:  A  systems-level  understanding  of  molecular  perturbations  is  crucial  for 
evaluating  chemical-induced  toxicity  risks  appropriately,  and  for  this  purpose 
comprehensive  gene  expression  analysis  or  toxicogenomics  investigation  is  highly 
advantageous.  The  recent  accumulation  of  toxicity-associated  gene  sets  (toxicogenomic 
biomarkers),  enrichment  in  public  or  commercial  large-scale  microarray  database  and 
availability  of  open-source  software  resources  facilitate  our  utilization  of  the 
toxicogenomic data. However, toxicologists, who are usually not experts in computational 
sciences, tend to be overwhelmed by the gigantic amount of data. In this paper we present 
practical  applications of  toxicogenomics  by utilizing biomarker gene sets and a simple 
scoring  method  by  which  overall  gene  set-level  expression  changes  can  be  evaluated 
efficiently. Results from the gene set-level analysis are not only an easy interpretation of 
toxicological  significance  compared  with  individual  gene-level  profiling,  but  also  are 
thought to be suitable for cross-platform or cross-institutional toxicogenomics data analysis. 
Enrichment in toxicogenomics databases, refinements of biomarker gene sets and scoring 
algorithms and the development of user-friendly integrative software will lead to better 
evaluation of toxicant-elicited biological perturbations. 
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1. Introduction 
The  term  ‗toxic  agent‘  can  be  defined  as  any  substance  that  causes  harmful  effects  on  living 
organisms,  but  in  general,  such  hazardous  effects  are  substantially  dependent  on  the  chemical‘s 
exposure level. For instance, dietary salt may cause nephrotoxicity if an extreme amount is ingested at 
any  time;  however,  do  we  consider  sodium  chloride  a  toxic  agent?  This  is  not  the  case  because 
ordinarily we only need a spoon of salt for cooking and that amount will not harm healthy human 
bodies. In addition, in the case of pharmaceutical drugs, any chemical can be toxic when overdosed, 
and what makes them beneficial or toxic depends on their dose levels. Various types of preclinical 
toxicity  studies  are  required  before  starting  a  human  clinical  trial  to  collect  information  on  the 
toxicological profile such as target organs of toxicities, dose-response profile, recovery, toxicokinetics, 
genotoxicity, teratogenicity and carcinogenicity, using a sufficient number of experimental animals. 
However, even after a long and costly preclinical toxicity evaluation, species difference in mechanism 
of action (MOA) between humans and animals sometimes brings about unpredictable toxicities in 
humans [1]. Furthermore, a chemical once regarded as non-toxic could cause exaggerated toxicity in 
case  undesirable  chemical-chemical  interaction  occurs  through  inhibition  or  induction  of  ABC 
transporters  [2]  or  hepatic  drug  metabolizing  enzymes  [3].  To  evaluate  and  manage  the  potential 
hazardous risks of the chemicals, it is desirable to gain insight into the chemical-induced MOA in the 
target  organ  of  toxicity,  by  which  we  can  appropriately  evaluate  whether  the  chemical  should  be 
regarded as toxic or not according to its overall risk/benefit property. 
For living organisms, it is sometimes necessary to modulate biological homeostasis to overcome 
potential  hazardous  effects  caused  by  chemical  exposure.  For  example,  administration  of 
anticonvulsant phenobarbital to rats causes liver hypertrophy, which is associated with induction of 
hepatic drug metabolizing enzymes such as CYP2B and CYP3A through the activation of the nuclear 
receptor CAR [4]. Although an increase in liver weight may look like a deleterious perturbation of 
hepatic homeostasis, toxicologists usually regard it as a non-toxic but rather a desirable response or 
adaptive response for the body. This is because such hepatic enzyme induction facilitates efficient 
metabolism and disposition of the exposed chemicals. In a systems-biological point of view, such liver 
system  is  called  ‗robust‘,  not  ‗homeostatic‘  against  phenobarbital  exposure  [5],  where  biological 
systems  are  not  static  but  exhibit  dynamic  molecular  reconstructions  to  maintain  their  cellular 
functional integrity. From this perspective, drug-induced toxicity can be defined as a ‗collapse of the 
biological robustness by drug exposure‘. The recent advancement in Systems Biology is supported by 
dramatic advances in functional genomics techniques, especially the microarray technique by which 
expression levels of tens of thousands of genes can be measured simultaneously. Application of the 
microarray  technique  to  toxicology  research  is  called  toxicogenomics  (TGx),  and  is  now  widely 
utilized by pharmaceutical scientists in drug development [6]. The major problem in utilizing the TGx 
technique  lies  in  its  huge  data  size,  as  well  as  the  complexity  of  the  systems-level  molecular 
interactions.  We  cannot  avoid  performing  multivariate  analyses  to  handle  huge  data  sets,  but Int. J. Mol. Sci. 2010, 11                       
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toxicologists  usually  struggle  to  implement  complicated  statistical  analysis.  To  overcome  such 
difficulties, an easy, simple and practical analytical flow is desired. In this paper, we present practical 
methods of TGx data analysis for profiling chemical-elicited molecular perturbations using an open 
source analytical software, which will lead to better and easier utilization of TGx data to understand 
the MOA of toxicities. 
2. Advancement of Toxicogenomics 
2.1. Toxicogenomic Biomarker Gene Sets 
In 2001, it was reported that the hepatic gene expression profiles in rats following treatment with 
various  chemicals  showed  clear  chemical-specific  patterns  when  measured  with  the  microarray 
technique [7,8]. Such chemical-specific changes in the transcriptome profile leads to changes in the 
proteome profile, the metabolome profile and eventually the tissue-level phenotypes. Thus, it is natural 
that  the  transcriptome  profile  would  contain  a  significant  degree  of  information  for  biological 
conditions at the moment, which may lead to a profound understanding of chemical-induced molecular 
perturbations. However, such chemical-specific gene expression data contain mixed molecular events 
that reflect complicated interactions among biological pathways such as xenobiotic metabolism, stress 
response, energy metabolism, protein synthesis/degradation, mRNA transcription/degradation, DNA 
repair/replication,  cell  proliferation/cell  death  control,  etc.  Microarray  analysis  measures  tens  of 
thousands of gene expression levels simultaneously, and is usually too complicated to appropriately 
interpret the significance of the gene expression changes at a time. Instead, it would be more practical 
to focus on the data for certain gene sets whose expression levels are closely associated with certain 
biological functions like glycolysis and cell proliferation. Such gene sets can be prepared from public 
information such as PubMed literature search, Gene Ontology [9], KEGG [10] and GenMAPP [11] 
biological  pathway  information.  In  addition,  a  number  of  gene  sets  have  been  reported  whose 
expression levels are closely associated with certain toxicological endpoints, or TGx biomarker gene 
sets [12] such as cell injury [13], carcinogenicity [14,15], phospholipidosis [16,17] and glutathione 
depletion [18,19]. These TGx biomarkers can then be utilized for evaluation, diagnosis or prediction of 
toxicity based on their expression changes. As shown in Figure 1, it is much more informative and easy 
to interpret the microarray data by focusing on certain gene sets rather than observing whole data sets 
(i.e., >30,000 gene probe sets in the case of Affymetrix GeneChip system). However, it is still too 
complicated  when  we  need  to  handle  a  number  of  biomarker  gene  sets  at  a  time.  Because 
pharmaceutical toxicologists are usually not experts in handling vast amounts of data sets, it is crucial 
to develop user-friendly analytical software whose output is clear enough to interpret the toxicological 
significance. 
2.2. Public and Commercial Microarray Database 
A  high  quality  and  large-scale  reference  microarray  database  is  desired  for  an  appropriate 
interpretation  of  TGx  data.  A  number  of  public  databases  are  currently  available,  such  as  Gene 
Expression Ominibus (GEO) [20], ArrayExpress [21], Chemical Effects in Biological Systems (CEBS) 
[22],  Comparative  Toxicogenomics  Database  (CTD)  [23]  or  EDGE  [24].  In  addition,  the Int. J. Mol. Sci. 2010, 11                       
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Toxicogenomics Project in Japan (http://wwwtgp.nibio.go.jp/index.html) and the InnoMed PredTox 
Consortium (http://www.innomed-predtox.com/) developed large-scale toxicogenomic databases, both 
of which contain microarray datasets for well-studied toxicants, as well as proprietary drugs using both 
in vivo and in vitro systems. 
Figure 1. Expression profiling for toxicogenomic biomarker gene sets. Gene sets whose 
expression levels are closely associated with cell proliferation, glutathione metabolism and 
inflammatory responses are presented. The heat map represents gene expression changes, 
where up-regulation, no change and down-regulation are colored in red, white and blue, 
respectively. 
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2.3. Open Source Software 
Development of open source software is another driving factor of the recent advances in functional 
genomics  research  [25], although in  many cases  they require users  to  possess a  certain  degree of 
computational  skills.  In  this  paper,  Bioconductor  [26]  (http://www.bioconductor.org/),  which  is 
implemented  on  the  statistical  software  R  [27]  (http://cran.r-project.org/),  GraphViz 
(http://www.graphviz.org/) and Cytoscape [28] (http://www.cytoscape.org/) were actually utilized and 
the results are presented. 
3. Practical Application of TGx Database and Biomarkers 
3.1. Scoring the Gene Set-Level Expression Changes  
As stated before, the process of data analysis and interpretation of the results becomes increasingly 
complex  when  we  handle  large-scale  microarray  data  sets  and  multiple  TGx  biomarker  gene  sets 
simultaneously. To facilitate our understanding of the toxicological significance based on the TGx data, 
a simple scoring strategy was introduced to evaluate gene set-level expression changes. Figure 2 shows 
the general concept on how microarray data and multiple TGx biomarker gene sets can be processed to Int. J. Mol. Sci. 2010, 11                       
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generate a simple score for each TGx biomarker gene set, by which toxicologists can identify which 
biological endpoints were affected by chemical exposure, and thereby can evaluate the toxicological  
significance efficiently. 
In the Toxicogenomics Project in Japan, a large-scale TGx database called the Toxicogenomics  
Project-Genomics Assisted Toxicity Evaluation system (TG-GATEs) was developed that consisted of 
Affymetrix  GeneChip  data  for  approximately  150  prototypical  toxicants  on  rat  liver,  kidney, 
hepatocytes and human hepatocytes [29]. In the TG-GATEs system, an expression ratio-based scoring 
method called ‗TGP1 score‘ was utilized to facilitate understanding of the toxicological significance 
based on the TGx data set [30]. 
The TGP1 score is calculated by multiplying two elements: one element represents an index for the 
―overall  direction  of  the  expression  change  per  probe  set‖,  and  the  other  represents  the  ―overall 
magnitude of the expression change per gene‖ of the Biomarker X gene set. The sign of the first index 
will be either positive or negative when the overall expression changes of the genes in Biomarker X 
were up- or down-regulated, respectively, and will be expected to approach zero when the direction of 
expression changes is divergent. The second index is always positive and will be higher when the 
expression change levels of the genes show a higher value. Collectively, the TGP1 score will be higher 
when  the  genes  included  in  Biomarker  X  show  uniform  up-regulation  with  higher  expression  
changing levels. 
Figure 2. Scoring multiple toxicological endpoints using toxicogenomics data. Multiple 
toxicological  endpoint-associated  gene  sets  or  TGx  biomarkers  need  to  be  prepared  in 
advance, and the overall expression changing levels for each gene set are calculated by 
certain  algorithms  such  as  the  D-score,  by  which  affected  levels  for  each  biological 
pathway can be evaluated intuitively. 
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3.2. Differentially-Regulated Gene Score (D-score) 
The TGP1 score was found to be useful for efficient comprehension of large-scale microarray data 
sets.  However,  the  TGP1  score  calculation  treats  both  low  and  high quality gene expression data 
equally, and therefore the calculated score would be flawed if low quality data was involved in the 
calculation. To overcome this shortcoming, we introduced a new scoring method called Differentially-Int. J. Mol. Sci. 2010, 11                       
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expressed gene score (D-score) [31], where the data quality as well as the expression changing level 
for each gene is considered in the score calculation. Thus, the calculated score is much more reliable 
compared with the TGP1 score.  
Figure  3  represents  D-scores  for  microarray  data  on  rat  livers  treated  with  one  of  the  four 
hepatotoxicants: acetaminophen (APAP), phenobarbital (PB), clofibrate (CFB) or acetamidofluorene 
(AAF) using 10 biomarker gene sets for score calculation. Stimulation of glutathione depletion and 
inflammation  by  APAP,  induction  of  Cyp2b  and  Cyp3a  genes,  induction  of PPAR  by CFB and 
induction  of  Cyp1a  genes  are  evident  by  D-score  analysis  results  (Figure  3(A)),  where  the  
dose-dependent stimulation of these endpoints or genes can also be evaluated (Figure 3(B)). These 
results demonstrate that TGx biomarker gene sets and the D-score calculation method dramatically 
facilitate the interpretation of the TGx data.  
Figure 3. Detection of affected toxicological endpoints by D-score. (A) Rats were treated 
with prototypical hepatotoxicants acetaminophen (APAP), phenobarbital (PB), clofibrate 
(CFB) or acetamidofluorene (AAF), and the hepatic microarray data were obtained at 3, 6, 
9 and 24 h after treatment. The D-score highlights the activated toxicological endpoints 
elicited by the chemicals: glutathione depletion and inflammation by APAP, Cyp2b/Cyp3a 
induction by PB, PPAR activation by CFB and Cyp1 induction by AAF; (B) All the  
D-scores  except  for  that  of  Cyp2b  exhibited  a  clear  dose-response.  Data  are  reprinted  
from [31] with permission from Elsevier. 
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3.3. Inference of Gene Set-Level Network Structure Using a TGx Database  
Previous studies reported inconsistency of interlaboratory/inter-platform microarray results [32,33], 
while  others  have  reported  good  concordance  among  laboratories [34–36]  or  inconclusive  results 
[37,38]. Because a gene set-level or biological pathway-level analysis has been reported to be more 
robust  and  comparable  for  microarray  data  sets  obtained  from  different  studies  [39,40],  we 
hypothesized that the biological pathway-level interactions could be better evaluated using D-scores for 
multiple  gene  sets  as  compared  with  generic  molecular  network  analysis  methods,  which  were 
conducted with individual gene-by-gene-level analysis [41]. We inferred the gene set-level network 
structure  using  a  large-scale  TGx  database,  TG-GATEs,  and  a  total  of  58  gene  sets  [42]  with  a 
Gaussian  graphical model (GGM) algorithm to calculate partial correlation coefficients among the 
gene sets [43]. In addition to gene expression data, we also included changing levels of phenotypic data 
such as organ weight, blood chemistry and hematology parameters for calculation. 
The inferred network presented in Figure 4 was found to contain a number of toxicologically-relevant 
gene  set—gene  set  and  gene  set-phenotype  relationships,  such as  blood  glucose level  and hepatic  
glycolysis-associated gene sets, or blood aminotransferase enzyme activity and inflammation-associated 
gene  sets  [42].  These  results  demonstrate  that  the  retrospective  network  inference  using  a  GGM 
algorithm  successfully  highlighted  toxicologically  significant  gene  set-  and  phenotype-level 
relationships  from  a  large-scale  TGx  database.  Furthermore,  microarray  data  set  obtained  outside  
TG-GATEs was found to be well compatible with the network structure inferred based on TG-GATEs 
[42],  suggesting  that  the  gene  set-level  network  structure  was  robust  enough  to  be  applicable  for 
external microarray data sets. 
4. Case Study: Bromobenzene-Induced Molecular Perturbation  
In this section, a case study is presented for evaluating hepatic molecular perturbations elicited  
by 300 mg/kg bromobenzene (BBz) treatment in rats. D-score was calculated for a total of 58 gene sets 
and the calculated score was  presented as  either a radar chart (Figure 5), heat  map (Figure 6) or 
network structure (Figure 7). 
4.1. Radar Chart Presentation 
Figure 5 shows the time course of absolute D-score values presented in radar charts, where a total of  
58  gene  sets,  a  detailed  gene  list  which  has  been  reported  previously  [42],  were  used  for  score 
calculation. Significant biological perturbations became evident at 6 h after BBz treatment, where DNA 
damage- and Glutathione depletion-associated gene sets exhibited high D-scores. BBz is reported to 
cause  hepatic  glutathione  depletion  through  the  generation  of  reactive  metabolites  [44],  which  is 
concordant with the high D-score for the glutathione depletion-associated genes. At 12 h, D-scores for 
Oxidative  stress-  and  Inflammation-associated  gene  sets  exhibited  high  scores,  suggesting  that 
oxidative stress, supposedly associated with glutathione depletion, induced liver injury, which was 
followed  by  an  inflammatory  response.  Gluthatione  homeostasis-associated  genes,  which  include 
glutathione synthesis-related genes, were also activated at 12 h, which would contribute to feedback 
up-regulation  of  glutathione  synthesis  against  acute  glutathione  depletion.  The  D-scores  for Int. J. Mol. Sci. 2010, 11                       
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Inflammation- and DNA damage-associated gene sets became considerably high at 24 h after BBz 
treatment,  suggesting  the  level  of  liver  injury  progressed  in  spite  of  activation  of  Glutathione 
homeostasis-associated genes. 
Figure 4. Gene set- and phenotype-level network analysis. A large-scale TGx database,  
TG-GATE, was used for extracting statistically significant relationships among gene sets 
and phenotypes by utilizing a GGM algorithm. The network consists of D-scores for 58 
gene  sets,  as  well  as  changing  levels  of  phenotype  data  such  as  organ  weight,  blood 
chemistry  and  hematology.  Purple  and  green  represent  positive  and  negative  partial 
correlation coefficients, respectively, and the width of the lines represents strength of the 
correlation  measured  with  partial  correlation  coefficient.  The  network  was  drawn  with 
open-source software Cytoscape. 
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Figure 5. Time course of D-score: Radar chart presentation. D-scores were calculated for 
rat livers harvested at 2, 6, 12 and 24 h after bromobenzene treatment, and are presented in 
a radar chart. The red line indicates the D-score for each gene set, and the blue circle 
indicates a D-score = 20 for each gene set. Detailed information for the gene sets used can 
be obtained in a previous report [42]. 
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4.2. Heat Map Presentation 
Time course transition of D-score profiles is presented in Figure 6, which clearly demonstrates the 
molecular mechanisms of BBz-elicited toxicity: Glutathione depletion and oxidative stress are the first 
triggers  after  BBz  treatment,  which  caused  cell  death  suggested  by  up-regulation  of  DNA  
damage-associated genes. This was followed by inflammation, tissue repair, as well as activation of 
antioxidant  factors  such  as  up-regulation  of  glutathione  synthesis-related  genes,  glutathione  
S-transferase (Gst) genes or aldo-keto reductase (Akr) genes. Int. J. Mol. Sci. 2010, 11                       
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Figure 6. Time course of D-score: Heat map presentation. Red and blue indicate high and 
low D-scores, or up- and down-regulation for each gene set, respectively. The heat map 
indicates  that  the  first  trigger  invoked  by  bromobenzene  exposure  was  glutathione 
depletion and associated oxidative stress responses, followed by cell death, inflammation 
and up-regulation of antioxidant factors, as well as down-regulation of energy metabolism 
and drug metabolizing enzymes. 
 
4.3. Supervised Network Structure Presentation 
The  BBz-elicited  biological  responses  can  also  be  visualized  with  the  pre-defined  biological 
network structure. Figure 7 represents a D-score profile at 24 h after BBz treatment, where gene sets 
associated with glutathione depletion, oxidative stress and inflammation were up-regulated (colored in 
red). On the other hand, gene sets associated with energy metabolism (i.e., cholesterol synthesis and 
glycolysis) were down-regulated (colored in blue). Thus, the systems-level biological responses can be 
intuitively characterized with the supervised gene set-level biological network. However, the network 
structure  should  be  kept  up-to-date  in  a  timely  manner  when  novel  toxicological  knowledge  has  
been obtained. Int. J. Mol. Sci. 2010, 11                       
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Figure  7.  Network  structure  presentation  of  D-scores.  Biological  and  toxicological 
relationships among gene sets were visualized as a supervised network using GraphViz 
software.  The  D-scores  calculated  for  microarray  data  on  rat  livers  at  24  h  after 
bromobenzene treatment are presented in a network structure using GraphViz software, 
where red and blue indicate high and low D-scores, respectively. The network demonstrates 
oxidative stress and DNA damage were induced by bromobenzene treatment, while sterol 
metabolism was down-regulated. 
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5. Conclusion 
Systems-level understanding of molecular perturbations is crucial for evaluating chemical-induced 
toxicity risks. Microarray data provides comprehensive gene expression responses against chemical 
exposure,  and therefore  the TGx  approach is highly advantageous for understanding systems-level 
biological perturbations. To solve the difficulty in handling huge amounts of TGx data sets, preparation 
of TGx biomarker gene sets and implementation of gene set-level data analysis are effective. The 
general flow of TGx data analysis is shown in Figure 8. The first step is to identify biological pathways 
that  were  affected  by  the  chemical  exposure,  for  which  a  radar  chart  presentation  will  be  useful  
(Figure 8(A)). Detailed expression analysis of the individual genes will be needed to focus on the 
affected biological pathways (Figure 8(B)). When available, large-scale TGx reference database will be 
utilized for comparative analysis to appropriately evaluate the toxicological significance (Figures 8(C) 
and  8(D)).  To  comprehend  the  systems-level  molecular  dynamics,  relationships  among  pathways 
should be taken into consideration (Figure 8(F)). Such analytical flow can be automated if appropriate 
computational skills are available. Refining toxicogenomic biomarker gene sets, scoring algorithm and 
development of user-friendly integrative software will substantially help the utilization of the TGx data 
set  to  evaluate  biological  response  by  which  hazardous  effects  of  exposed  chemicals  could  be  
appropriately managed.  Int. J. Mol. Sci. 2010, 11                       
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Figure  8.  Analytical  flow  for  toxicity evaluation  using  TGx data. (A) Radar chart for  
D-scores using 58 gene sets; (B) Box plot for comparative analysis using a reference TGx 
database;  (C)  Heat  map  for  individual  genes;  (D)  TGx  reference  database  and  TGx 
biomarker knowledgebase; (E) Unsupervised gene set-level network inference to extract 
toxicological relationships among pathways; (F) Supervised gene set-level network. 
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